Completed
Rapid advances in cancer research, diagnostic testing, and targeted therapies are transforming the landscape of cancer diagnosis and care – helping to improve patient outcomes, but also increasing the complexity of diagnosis and subsequent care. This workshop examined opportunities to ensure that patients have access to appropriate oncologic pathology and imaging expertise and technologies to inform their diagnosis, treatment planning, assessment of treatment response, and oncologic surveillance. Workshop sessions considered strategies to develop and maintain a workforce with oncologic imaging and pathology competencies and the role of new technologies and models of care to improve access to these expertise areas.
Featured publication
Workshop
·2018
Rapid advances in cancer research, the development of new and more sophisticated approaches to diagnostic testing, and the growth in targeted cancer therapies are transforming the landscape of cancer diagnosis and care. These innovations have contributed to improved outcomes for patients with cancer...
View details
Description
An ad hoc committee will plan and host a 1.5-day public workshop that will feature invited presentations and panel discussions. Workshop participants will examine strategies to ensure that patients have access to appropriate oncologic pathology and imaging expertise and technologies to inform their cancer diagnosis, treatment planning, assessment of treatment response, and oncologic surveillance. Potential strategies that will be explored include opportunities to develop and maintain a workforce with oncologic imaging and pathology competencies and the role of new technologies and models of care to improve access to this expertise.
Participants will be invited to discuss topics that may include:
- Training needs for clinicians (specialists and generalists) who interpret pathology and imaging results for patients with cancer.
- Models of care that can improve patient access to cancer specialists in pathology and radiology (e.g., telemedicine), and implications on patient outcomes and clinical practice.
- Opportunities to enhance collaboration among pathologists, radiologists, and oncologists to improve diagnostic testing and treatment decision-making for patients with cancer.
- Challenges and opportunities for technologies to facilitate improved diagnostic decision-making among specialists and generalists (e.g., guidelines, appropriate use criteria, computer-aided detection, diagnostic decision support).
- Potential role of new advances in imaging and pathology technologies to improve decision making for patients with cancer.
The committee will develop the agenda for the workshop sessions, select and invite speakers and discussants, and moderate the discussions. A proceedings of the presentations and discussions at the workshop will be prepared by a designated rapporteur in accordance with institutional guidelines.
Collaborators
Sponsors
American Association for Cancer Research
American Cancer Society
American College of Radiology
American Society of Clinical Oncology
Association of American Cancer Institutes
Centers for Disease Control and Prevention (CDC)
Flatiron Health
Helsinn Therapeutics (U.S.), Inc.
LiveSTRONG Foundation
Merck
National Cancer Institute
National Comprehensive Cancer Network
National Institutes of Health
Novartis Oncology
Oncology Nursing Society
Pfizer Inc.
Staff
Sharyl Nass
Lead
Erin Balogh
Lead
Cyndi Trang